Answers are grounded in this paper and cite their sources.
Background Amiodarone-induced thyrotoxicosis is a therapeutic challenge, particularly in patients with severe underlying cardiac comorbidities. In refractory cases, urgent thyroidectomy provides definitive treatment, but data on perioperative outcomes and cardiac function remain limited. Methods Retrospective cohort study of all patients undergoing total thyroidectomy for amiodarone-induced thyrotoxicosis between 2011 and 2024 at a tertiary center. Clinical, biochemical, perioperative, and cardiac data were collected from hospital records and the EUROCRINE ® registry. Outcomes included perioperative morbidity, one-year mortality and changes in left ventricular ejection fraction. Results Thirty-four patients (median [IQR] age 63.5 [52.8-71.0] years, 79.4% male) with new-onset amiodarone-induced thyrotoxicosis underwent total thyroidectomy after 68.0 [42.5–95.8] days of medical treatment. Refractory thyrotoxicosis (85.3%) and worsening heart failure (14.7%) were the main indications. At the time of surgery, 82.4% had persistent overt thyrotoxicosis. Surgical morbidity was low: one transient recurrent laryngeal nerve palsy, four cases of transient hypoparathyroidism and no bleeding or wound infection occurred. One-year mortality was 2.9%: one patient died from unrelated causes. Median preoperative left ventricular ejection fraction was 41.0 [28.3-54.4]%. Paired analysis showed no significant differences between baseline, prior to the onset of amiodarone-induced thyrotoxicosis, and postoperative left ventricular ejection fraction, though patients with preserved baseline function (≥50%) experienced a significant decline following the onset of amiodarone-induced thyrotoxicosis (p = 0.03 1 ). Conclusion Thyroidectomy represents a valuable treatment option for refractory amiodarone-induced thyrotoxicosis, with low morbidity and mortality in this cohort. Exploratory analyses indicate that left ventricular ejection fraction remains broadly stable relative to baseline following resolution of thyrotoxicosis. However, in patients with preserved baseline ejection fraction, cardiac function declined significantly during the thyrotoxic state.
No takes yet. Share an insight, caveat, or question.
Köster et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: